Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs77375493
rs77375493
CUI: C1318533
Disease: Secondary polycythemia
Secondary polycythemia
0.060 GeneticVariation BEFREE The V617F JAK2 mutation was absent within the patients with secondary erythrocytosis or thrombocytosis. 19939582

2011

dbSNP: rs77375493
rs77375493
CUI: C1318533
Disease: Secondary polycythemia
Secondary polycythemia
0.060 GeneticVariation BEFREE The Janus kinase 2 (JAK2) V617F mutation was present in 34 (85.3%) PV, 2 (50%) IE, 1 (50%) apparent and no secondary erythrocytosis cases. 17454193

2007

dbSNP: rs77375493
rs77375493
CUI: C1318533
Disease: Secondary polycythemia
Secondary polycythemia
0.060 GeneticVariation BEFREE We could confirm a very high sensitivity, specificity and utility of the Jak2(V617F) mutation for differential diagnosis between PV and SE. 17852451

2007

dbSNP: rs77375493
rs77375493
CUI: C1318533
Disease: Secondary polycythemia
Secondary polycythemia
0.060 GeneticVariation BEFREE However, until the recent description of the constitutively activating V617F point mutation of the Janus 2 tyrosine kinase (JAK2)--a high-frequency molecular marker that is extremely specific for clonal chronic myeloproliferative disorders--distinction of PV from secondary erythrocytosis or other conditions has often been difficult. 16827884

2006

dbSNP: rs77375493
rs77375493
CUI: C1318533
Disease: Secondary polycythemia
Secondary polycythemia
0.060 GeneticVariation BEFREE However, compared with the PRV-1 assay, mutation screening for JAK2(V617F) displayed greater accuracy in distinguishing PV from SP. 16197445

2005

dbSNP: rs77375493
rs77375493
CUI: C1318533
Disease: Secondary polycythemia
Secondary polycythemia
0.060 GeneticVariation BEFREE V617F was not identified in patients with systemic mastocytosis (n = 28), chronic or acute myeloid leukemia (n = 35), secondary erythrocytosis (n = 4), or healthy controls (n = 160). 15920007

2005